Aros Pharma
Copenhagen
About Aros Pharma
Aros Pharma is developing a new effective therapy reducing the pain associated with Irritable Bowel Syndrome (IBS). The company has acquired all rights to a new chemical entity that can negatively modulate the activity of acid sensors in the gastrointestinal tract. These acid sensors are believed to play a central role in pain associated with IBS.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $100K – $500K
- Last round: Series Unknown (Dec 2010)
- Website: arospharma.com
Industries & Categories
Developer Tools, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/aros-pharma-2292845 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.